Order Supartz® IT for Clinics

Supartz® IT is a sterile intra-articular sodium hyaluronate preparation supplied as five 2.5 mL prefilled syringes for professional knee joint administration. Licensed clinics and healthcare professionals can order Supartz® IT for established viscosupplement workflows, with packaging that supports series-based scheduling, lot documentation, and treatment-room readiness.

Each syringe is intended for single-use administration by trained clinicians using aseptic technique. Orthopedic, rheumatology, sports medicine, and interventional pain teams may incorporate this Supartz IT injection into broader knee osteoarthritis protocols according to the treating clinician’s assessment and facility procedures.

Supartz IT Price, Pack Size, and Ordering Details

Sign in with a professional account to view the current Supartz IT price and clinic purchasing details. The supplied pack contains 5 x 2.5 mL prefilled syringes, which helps practices plan inventory around a defined injection series or coordinated clinic sessions.

Supartz® IT is commonly evaluated by clinics that need consistent hyaluronan supply for knee OA injection services. Procurement teams should match pack quantity, storage requirements, lot numbers, and expiry dates with internal protocols before scheduling patients. Multi-site groups may also use purchase history and invoice records to keep ordering aligned across locations.

Quick tip: Build reorder points around scheduled series volume, not only current shelf count.

What Supartz Is Used For in Clinical Practice

Supartz® IT is a viscosupplement for knee osteoarthritis. In clinical use, sodium hyaluronate is injected into the knee joint to supplement synovial fluid, the fluid that helps lubricate and cushion joint movement. The FDA-approved Supartz labeling describes use for pain in osteoarthritis of the knee in patients who have not responded adequately to conservative non-drug therapy and simple analgesics.

A hyaluronic acid knee injection does not replace evaluation, imaging, rehabilitation planning, weight-management counseling, bracing, analgesic review, or other components of musculoskeletal care. It is one tool within a clinician-directed treatment pathway. Practices that provide injection-based knee care can browse related products in orthopedic injections and adjacent therapies in rheumatology.

Supartz® IT is administered intra-articularly, meaning into the joint space. Clinics typically perform the procedure with sterile preparation, appropriate local workflow controls, and post-procedure observation consistent with facility policy. Landmark-guided or image-guided techniques may be used according to clinician preference, anatomy, and practice standards.

How Sodium Hyaluronate Works in the Knee

The active component is hyaluronic acid presented as sodium hyaluronate. Hyaluronan contributes to the viscoelastic properties of synovial fluid, which means it helps the fluid behave as both a lubricant and a shock-absorbing material during joint motion.

In osteoarthritis, synovial fluid quality and joint mechanics can change. Intra-articular sodium hyaluronate is used to supplement that environment and support smoother movement during a treatment plan. Individual response varies, so follow-up assessment remains important for documenting function, comfort, range of motion, and future care needs.

For background on the brand and clinical positioning, see the Supartz brand assortment and the article on Supartz in osteoarthritis pain management.

Prefilled Syringe Format and Clinic Workflow

Supartz® IT is supplied as a prefilled syringe, which reduces preparation steps compared with products that require drawing medication from a vial. The 5-syringe pack can support appointment planning, room setup, medical record documentation, and inventory reconciliation.

• Pack configuration: 5 x 2.5 mL prefilled syringes.
• Product SKU: 81523.
• Format: sterile, single-use intra-articular syringe.
• Active ingredient: hyaluronic acid as sodium hyaluronate.
• Use setting: professional knee joint administration in controlled clinical environments.
• Documentation support: lot and expiry details assist clinic records and quality checks.

Because each syringe is single-use, staff should follow facility policy for sterile handling, sharps disposal, and unused material management. The format can fit ultrasound-guided or landmark-guided injection rooms when those approaches are part of the clinic’s standard practice.

Supartz IT Dosing and Scheduling Considerations

Supartz IT dosing and visit cadence should follow the product labeling and the clinician’s protocol for the individual patient. The current pack configuration supports a multi-injection series, and many clinics plan viscosupplement appointments with consistent spacing, follow-up evaluation, and documentation at each visit.

Operationally, it is useful to confirm laterality, treatment plan, prior injections, allergy history, current knee status, and any planned aspiration or imaging before opening the syringe. That verification step protects the sterile field and helps reduce room delays.

Clinics comparing series-based viscosupplements may want to review format, syringe count, active ingredient, and handling differences. The Supartz and Euflexxa comparison discusses practical distinctions that can affect product standardization.

Expected Timeline and Follow-Up Questions

Patients often ask how long a Supartz injection lasts or when improvement may occur. The answer varies by disease severity, activity level, prior response, and the overall knee care plan. Clinics should set expectations carefully: response may not be immediate, and some patients may not obtain meaningful relief.

Follow-up visits are useful for assessing pain, stiffness, function, adverse reactions, and whether additional interventions are needed. Documentation can include baseline symptoms, injection date, lot number, treated knee, technique, tolerance, and the next planned visit.

Injection discomfort can occur, as with other intra-articular procedures. Staff can help by explaining the room workflow, maintaining sterile technique, positioning the patient appropriately, and giving facility-approved post-procedure instructions.

Safety, Side Effects, and Professional Precautions

Supartz® IT should be used only in appropriate clinical settings by qualified professionals. Common local reactions reported with intra-articular hyaluronan products may include pain, swelling, warmth, redness, itching, bruising, or effusion around the treated knee. These reactions are usually assessed in the context of timing, severity, fever, mobility changes, and the patient’s medical history.

Clinicians should evaluate for infection, skin disease at the injection site, known hypersensitivity, inflammatory flare, significant effusion, anticoagulant use, bleeding risk, and other factors that may affect the procedure. Do not inject through infected or compromised skin. Facility protocols should address aseptic preparation, patient observation, escalation for concerning symptoms, and documentation of adverse events.

Serious complications are uncommon but require prompt evaluation when suspected. Patients should be instructed through clinic-approved materials to seek medical attention for severe pain, rapidly increasing swelling, fever, marked redness, or inability to bear weight after injection. Product-specific labeling and professional judgment should guide final use decisions.

Storage, Handling, and Documentation

Store and handle Supartz® IT according to the manufacturer’s labeling and your facility’s medication or device management procedures. Before use, staff should verify package integrity, expiry date, lot number, syringe presentation, and treatment-room readiness.

Med Wholesale Supplies serves licensed clinics and healthcare professionals with brand-name medical products sourced through verified supply channels. Orders can be supported with temperature-controlled handling when required and tracked US delivery. Maintain receiving records and reconcile shipped quantities with internal inventory logs.

For broader supply planning, clinics can review the pharmaceuticals category alongside procedural inventory. Compatible supplies, local policies, and staff training should be reviewed before expanding injection volume.

Comparable Viscosupplement Options

Clinics often standardize one or more hyaluronan products based on protocol preference, syringe presentation, contract terms, and provider experience. Supartz® IT may be considered alongside other knee OA viscosupplements when a practice evaluates series length, volume, handling, and documentation needs.

Related products include Euflexxa prefilled syringes, Hyalgan single syringe, Hymovis prefilled syringes, and Cingal. Selection should be directed by clinical protocol, labeling, patient factors, and procurement requirements.

For educational context on this injection class, the articles on rooster comb injections and cortisone and HA injections may help staff discuss category differences without substituting for product labeling.

Authoritative Sources

• FDA-approved Supartz labeling
• Peer-reviewed review of Supartz sodium hyaluronate
• NIAMS osteoarthritis information

This content is for informational purposes only and is not a substitute for professional medical advice.